HistoSonics

HistoSonics develops a non-invasive medical device platform using histotripsy, a focused ultrasound technology that mechanically destroys liver tumors at the cellular level by creating a "bubble cloud" effect. The company's system is designed to treat unresectable liver tumors and has received CE Mark approval in Europe and submitted applications to the FDA for kidney tumor treatment.